Xcout Intel
Herantis Pharma Oyj competitors & alternatives
The 12 closest competitors and alternatives to Herantis Pharma Oyj among health care companies — ranked by similarity to what Herantis Pharma Oyj actually does, not by market-cap band.
Subscribe to see Herantis Pharma Oyj’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Herantis Pharma Oyj
Herantis Pharma Oyj is a clinical-stage biotechnology company that develops disease-modifying therapies to halt or reverse the progression of neurodegenerative diseases. The company focuses on researching and advancing innovative treatments, such as its lead drug candidate HER-096, to address significant unmet medical needs.
Herantis Pharma Oyj at a glance
Herantis Pharma Oyj is a health care company headquartered in Finland. Xcout tracks 5 named people at Herantis Pharma Oyj, including Timo Veromaa (MD, PhD, eMBA, Chairman of the Board).
Herantis Pharma Oyj leadership
- Timo VeromaaMD, PhD, eMBA, Chairman of the Board
- Aki PrihtiBoard member
- Frans WuiteMD, MBA, Board Member
- Hilde FurbergMSc, Board Member
- Mats ThorénBoard member
Top 12 Herantis Pharma Oyj competitors
Ranked by semantic similarity — how close each company is to Herantis Pharma Oyj by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthcare
Headquartered in Clermont-Ferrand, France, Axoltis Pharma is a biotechnology company focused on developing novel therapeutic solutions to restore blood-brain barrier integrity and treat neurodegenerative diseases.
Similar health care company
AlzeCure Pharma is a Swedish clinical-stage biopharmaceutical company developing small-molecule therapies for neurodegenerative diseases, particularly Alzheimer’s disease and related cognitive disorders. Its programs target disease mechanisms and symptoms, serving patients with serious central nervous system conditions through potential prescription medicines.
Healthcare
Neusignal Therapeutics, Inc. is a Tokyo-based company focused on commercializing early-stage drug discovery from Tohoku with the goal of defeating dementia.
Similar health care company
H. Lundbeck is a global pharmaceutical company that focuses exclusively on researching, developing, and commercializing therapies for brain diseases such as neurology and psychiatry disorders. The company serves patients worldwide suffering from conditions like Alzheimer's disease, Parkinson's disease, migraine, depression, and schizophrenia.
Healthcare
Magnolia Neurosciences Corp is a New York City-based biotechnology company developing a new class of neuroprotective medicines. Operating out of the Alexandria Center for Life Science, the firm focuses on advancing innovative treatments for neurological conditions.
Healthcare
Cellestial Health is a privately held therapeutics development company spun out from the University of Cambridge in 2023 to create new treatments for Parkinson's disease and related conditions.
Healthcare
CureGenetics is a biotechnology company headquartered in Suzhou, China, focused on the development of gene and cutting-edge medical therapies.
Biotechnology
Harness Therapeutics Ltd. is a biotechnology company founded in 2023 and based in Cambridge, United Kingdom. The company focuses on RNA biology and the development of novel therapeutics for the treatment of neurodegenerative diseases.
Biotechnology
Argo Therapeutics is a Swiss biotechnology company headquartered in Allschwil, Switzerland, focused on neurodegenerative-disease therapeutics.
Biotechnology
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Biotechnology
Theranexus (THX Pharma) is a clinical-stage biopharmaceutical company that develops innovative therapeutic solutions for patients suffering from rare neurological diseases such as Batten disease, Niemann-Pick type C, and Gaucher disease. The company utilizes scientific research and antisense oligonucleotides to create targeted drug candidates addressing significant unmet medical needs.
Biotechnology
Falcon Therapeutics, Inc., in association with Skyhawk Therapeutics, conducts global clinical trials for Huntington's disease. The company serves patients with Huntington's disease by evaluating the small molecule splicing modifier SKY-0515 to lower mutant huntingtin protein levels and slow disease progression.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Herantis Pharma Oyj and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Herantis Pharma Oyjand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →